Jun 11, 2024 8:40am EDT NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America
May 13, 2024 4:05pm EDT NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
Apr 18, 2024 8:00am EDT NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
Apr 01, 2024 7:50am EDT NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Mar 27, 2024 9:00am EDT NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
Mar 21, 2024 9:00am EDT NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
Mar 04, 2024 8:30am EST NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
